3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Rectal Neoplasms
3
Hyperthermia
3
Uterine Cervical Neoplasms
2
Colorectal Neoplasms
2
Colonic Neoplasms
2
Urinary Bladder Neoplasms
1
Sarcoma, Synovial
1
Sarcoma
1
Rhabdomyosarcoma
1
Peritoneal Neoplasms
1
Neurofibrosarcoma
1
Neoplasm Metastasis
1
Liposarcoma
1
Leiomyosarcoma
1
Histiocytoma, Malignant Fibrous
1
Hemorrhage
1
Hemangiosarcoma
1
Fibrosarcoma
1
Condylomata Acuminata
1
Bone Neoplasms
1
Anus Neoplasms
1
Interventions
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
12
Vaccines, Synthetic
9
Vaccines
3
Papillomavirus Vaccines
3
Imiquimod
2
Duration of Therapy
2
human papillomavirus vaccine, L1 type 16, 18
1
Viusid
1
Vaccination
1
Tuberculin
1
Podophyllin
1
PRA1 protein, Candida albicans
1
Measles-Mumps-Rubella Vaccine
1
Hepatitis B Vaccines
1
Diathermy
1
Cyclophosphamide
1
Cryotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Condylomata Acuminata
×
Diathermy
×
Clear all
NCT03289260
2020-09-23
AdAM
Medical University Innsbruck
Phase 3
Unknown
200 enrolled